Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registry.
Gemicioglu B, Gokmen D, Can A, Sevinc C, Oguzulgen IK, Soyyigit S, Yakut T, Havlucu Y, Aydin O, Buhari GK, Sozener ZC, Bulut I, Beyaz S, Orcen C, Ozdemir SK, Keren M, Damadoglu E, Kalpaklioglu AF, Baccioglu A, Yalim SA, Yilmaz I, Kalkan IK, Uysal MA, Ozgun Niksarlioglu EY, Kalyoncu AF, Karakaya G, Erbay M, Nayci S, Tepetam FM, Gelincik A, Dirol H, Goksel O, Karaoglanoglu S, Erkekol FO, Isik SR, Yildiz F, Yavuz Y, Karadogan D, Bozkurt N, Seker U, Basyigit I, Baris SA, Ucar EY, Erdogan T, Polatli M, Ediger D, Gunaydin FE, Turk M, Pur L, Katran ZY, Sekibag Y, Aykac EF, Mungan D, Gul O, Cengiz A, Akkurt B, Ozden S, Demir S, Unal D, Aslan AF, Gumusburun R, Bogatekin G, Akten HS, Inan S, Erdinc M, Ogus AC, Kavas M, Yulug DP, Cakmak ME, Kaya SB, Alpagat G, Ozgur ES, Uzun O, Gulen ST, Pekbak G, Kizilirmak D, Donmez H, Arslan B, Cetin GP, Kara BY, Dursun AB, Karakis GP, Kendirlinan R, Ozturk AB, Simsek GO, Abadoglu O, Cerci P, Yucel T, Yorulmaz I, Tezcaner ZC, Tatar EC, Suslu AE, Ozer S, Dursun E, Yorgancioglu A, Çelik GE.
Gemicioglu B, et al. Among authors: kavas m.
Respir Med. 2024 Nov 29;236:107883. doi: 10.1016/j.rmed.2024.107883. Online ahead of print.
Respir Med. 2024.
PMID: 39617354
